Skip to main content
Signal8

HIRSCH DIDIER

SEC insider (Form 3/4/5 filer). CIK 0001226464. Director at SOPHiA GENETICS SA (SOPH) and 2 other issuers. 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 18, 2026. Located in BOSTON, MA.

Companies HIRSCH DIDIER has filed insider reports for

  • SOPHiA GENETICS SA (SOPH): Director
  • Knowles Corp (KN): Director
  • Azenta, Inc. (AZTA): Director
HIRSCH DIDIER profile photo

HIRSCH DIDIER

CIK: 0001226464

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

SOPHiA GENETICS SA logo
SOPH

SOPHiA GENETICS SA

Director
Knowles Corp logo
KN

Knowles Corp

Director
Azenta, Inc. logo
AZTA

Azenta, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • SOPHiA GENETICS SA logo
    SOPH

    SOPHiA GENETICS SA

    Jun 18, 2026
    Award
    Direct
    19.7K shares at avg. $5.46$108K
  • Knowles Corp logo
    KN

    Knowles Corp

    Apr 29, 2025
    Award
    Direct
    11.9K shares at avg. $15.98$190K
  • Azenta, Inc. logo
    AZTA

    Azenta, Inc.

    Nov 18, 2024
    Purchase
    Direct
    1K shares at avg. $39.50$40K

1-3 of 3